No Data
No Data
Zhihui Hong Kong Stock Early Insights | Two Departments: Establish a pricing mechanism for public data resource authorization Operation. LINGBAO GOLD (03330) announces a profit warning.
The National Development and Reform Commission and the National Bureau of Statistics issued a notice on establishing a pricing mechanism for the authorized operation of public data resources.
Announcement selection | New China Life Insurance expects a year-on-year profit increase of over 175% in 2024; LINGBAO GOLD is expected to see net income increase year-on-year by about 110% to 140%.
New China Life Insurance expects a year-on-year profit increase of over 175% in 2024; CHI MER LAND's annual sales exceed 42 billion yuan.
Express News | InnoCare and KeyMed Jointly Announce the License Agreement With Prolium for Cd20Xcd3 Bispecific Antibody Icp-B02
Express News | InnoCare Pharma - License Agreement With Prolium for Development and Commercialization of Icp-B02
INNOCARE (688428.SH): A subsidiary signed a licensing agreement for the CD20×CD3 bispecific antibody (ICP-B02/CM355) with Prolium.
Gelonghui, January 20th丨INNOCARE (688428.SH) announced that its subsidiary Peking INNOCARE Biomedical Technology Co., Ltd. (hereinafter referred to as "Peking INNOCARE"), Kangnuo Yabiomedical Technology (Chengdu) Co., Ltd. (hereinafter referred to as "Chengdu Kangnuo"), and Beijing Tiannuo Jiancheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Tiannuo Jiancheng," with Peking INNOCARE and Chengdu Kangnuo each holding 50% of the shares) have signed an exclusive licensing agreement (hereinafter referred to as "the Agreement") with Prolium Bioscience Inc. (hereinafter referred to as "Prolium").
Hong Kong stocks fluctuated | INNOCARE (09969) rose nearly 7% as its commercialization capability for Obinutuzumab rapidly materializes. Institutions expect there is still room for market share to increase.
INNOCARE (09969) has increased by nearly 7%. As of the time of writing, it has risen by 6.61%, priced at 5.81 Hong Kong dollars, with a transaction amount of 17.6155 million Hong Kong dollars.
No Data
